Diversified Trust CO Regeneron Pharmaceuticals, Inc. Transaction History

Diversified Trust CO

$3.3 Billion
Q4 2024

A detailed history of Diversified Trust CO transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Diversified Trust CO holds 2,330 shares of REGN stock, worth $1.69 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

2,330

Previous 1,207 93.04%

Holding current value

$1.69 Million

Previous $1.27 Million 30.84%

% of portfolio

0.05%

Previous 0.04%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 07, 2025	BUY	$701.85 - $1046.91 $788,177 - $1.18 Million	1,123 Added 93.04%	2,330 $1.66 Million
Q3 2024 Oct 07, 2024	SELL	$1024.09 - $1201.76 $2,048 - $2,403	-2 Reduced 0.17%	1,207 $1.27 Million
Q2 2024 Jul 16, 2024	BUY	$883.2 - $1071.19 $19,430 - $23,566	22 Added 1.85%	1,209 $1.27 Million
Q1 2024 Apr 18, 2024	BUY	$902.69 - $993.35 $16,248 - $17,880	18 Added 1.54%	1,187 $1.14 Million
Q4 2023 Jan 08, 2024	SELL	$775.18 - $881.7 $160,462 - $182,511	-207 Reduced 15.04%	1,169 $1.03 Million
Q3 2023 Nov 17, 2023	BUY	$692.45 - $844.37 $5,539 - $6,754	8 Added 0.58%	1,376 $1.13 Million
Q2 2023 Jul 18, 2023	BUY	$700.03 - $830.35 $9,800 - $11,624	14 Added 1.03%	1,368 $982,000
Q1 2023 Apr 07, 2023	BUY	$680.49 - $826.97 $23,817 - $28,943	35 Added 2.65%	1,354 $1.11 Million
Q4 2022 Jan 17, 2023	SELL	$705.89 - $766.39 $4,941 - $5,364	-7 Reduced 0.53%	1,319 $952,000
Q3 2022 Oct 14, 2022	SELL	$573.97 - $724.32 $21,810 - $27,524	-38 Reduced 2.79%	1,326 $913,000
Q2 2022 Jul 12, 2022	BUY	$548.35 - $738.84 $27,965 - $37,680	51 Added 3.88%	1,364 $806,000
Q1 2022 Apr 07, 2022	SELL	$595.12 - $698.43 $191,033 - $224,196	-321 Reduced 19.65%	1,313 $917,000
Q4 2021 Jan 13, 2022	SELL	$543.48 - $670.97 $34,782 - $42,942	-64 Reduced 3.77%	1,634 $1.03 Million
Q3 2021 Jan 13, 2022	BUY	$574.03 - $680.96 $65,439 - $77,629	114 Added 7.2%	1,698 $1.03 Million
Q2 2021 Jul 20, 2021	SELL	$472.8 - $558.54 $251,056 - $296,584	-531 Reduced 25.11%	1,584 $885,000
Q1 2021 May 10, 2021	BUY	$446.73 - $548.2 $381,060 - $467,614	853 Added 67.59%	2,115 $1 Million
Q4 2020 Jan 08, 2021	BUY	$478.3 - $607.98 $103,312 - $131,323	216 Added 20.65%	1,262 $610,000
Q3 2020 Oct 15, 2020	BUY	$544.75 - $658.21 $167,238 - $202,070	307 Added 41.54%	1,046 $586,000
Q2 2020 Jul 07, 2020	SELL	$493.32 - $643.92 $4,933 - $6,439	-10 Reduced 1.34%	739 $461,000
Q1 2020 Apr 10, 2020	BUY	$336.18 - $494.43 $4,706 - $6,922	14 Added 1.9%	749 $366,000
Q4 2019 Jan 09, 2020	BUY	$274.13 - $376.51 $201,485 - $276,734	735 New	735 $276,000
Q1 2019 May 22, 2019	SELL	$372.08 - $439.57 $1.35 Million - $1.6 Million	-3,630 Closed	0 $0
Q4 2018 Jan 18, 2019	BUY	$335.82 - $403.04 $10,074 - $12,091	30 Added 0.83%	3,630 $1.36 Million
Q2 2018 Jul 23, 2018	SELL	$284.6 - $344.99 $1,423 - $1,724	-5 Reduced 0.14%	3,600 $1.24 Million
Q3 2017 Oct 17, 2017	BUY	$431.38 - $504.0 $1.56 Million - $1.82 Million	3,605	3,605 $1.61 Million

Others Institutions Holding REGN

# of Institutions

1,488

Shares Held

85.7M

Call Options Held

1.53M

Put Options Held

1.44M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $77.5B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Diversified Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Diversified Trust CO with notifications on news.

Account

Diversified Trust CO Regeneron Pharmaceuticals, Inc. Transaction History